ZimVie
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, ZimVie sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
ZimVie: 10 sponsored US clinical trials, 3 recruiting.
ZimVie sponsors 10 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 6 completed. The most-studied condition in this pipeline is Edentulous Jaw, with 2 trials.
Top-decile sponsor footprint
ZimVie ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
10 total, page 1 of 1
A Clinical Study of the TSX Dental Implant System (Xpresso)
NCT06571812
An Observational Study of the T3 Pro Dental Implant System
NCT05498662
The Tether™ - Vertebral Body Tethering System Post Approval Study
NCT04505579
An Observational Clinical Study of the T3 Dental Implant System
NCT05062863
A Clinical Study of the T3 Short Dental Implant System
NCT04237545
A Clinical Study of the TSV Dental Implant System
NCT04236336
A Clinical Study of the Eztetic Dental Implant System
NCT03917927
A Prospective Study Evaluating the Performance of Nanotite Osseotite Implants When Placed by Graduate Student Programs
NCT00726063
A Study of Certain Prevail Implants Used for the Preservation of Crestal Bone in Short Fixed Bridge Cases.
NCT00728754
A Study of Osseotite Certain Prevail Implants Used to Support Short Fixed Bridges With Immediate Occlusal Loading.
NCT00728962
Therapeutic Areas
What is open in the ZimVie pipeline
3 recruiting of 10 indexed (30% open); 6 completed (60%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Edentulous Jaw (2 trials), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
ZimVie: open-pipeline peers nationwide
Peers matched on 10 registered trials and 30% open enrollment, not the therapeutic-area sidebar.
ZimVie sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 trials (± recruiting share)
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors near 30% open enrollment (± trial volume)
- Centre hospitalier de l'Université de Montréal (CHUM) · 30% recruiting · 10 trials
- Child Trends · 30% recruiting · 10 trials
- Jacques E. Chelly · 30% recruiting · 10 trials
- Jason Sperry · 30% recruiting · 10 trials
Related
What to do with this ZimVie page
10 registered trials is a research-attention snapshot, not an endorsement of ZimVie or any single study.
- 3 of ZimVie's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Edentulous Jaw is the condition ZimVie studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Edentulous Jaw trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
ZimVie pipeline card: 10 registered trials from official public datasets.Report a data error.